BIOLASE, Inc to Report Second Quarter 2022 Results on August 11, 2022
BIOLASE, the leader in dental lasers, will release its second quarter 2022 financial results on August 11, 2022, after U.S. market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BIOLASE, the leader in dental lasers, will release its second quarter 2022 financial results on August 11, 2022, after U.S. market close. A conference call will follow at 4:30 p.m. ET to discuss these results and corporate developments. Investors can participate by calling 877-545-0320 (U.S.) or +1 973-528-0002 (International) with the earnings code: 838343. The call will be accessible via a live and archived webcast on the BIOLASE Investor Relations Page. BIOLASE focuses on developing innovative dental laser systems for improved patient outcomes.
Details
News Market Reaction – BIOL
The recorded move for BIOL in the trading session of this news was +1.70%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
To access the live call, dial 877-545-0320 (U.S.) or +1 973-528-0002 (International) and provide the following earnings code: 838343.
A live and archived webcast of the conference call will be accessible on the BIOLASE Investor Relations Page. In addition, a phone replay will be available approximately two hours following the end of the call, and it will remain available for one week. To access the call replay dial 877-481-4010 or +1 919-882-2331 (International) and enter replay passcode: 46222.
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 302 patented and 31 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
Contacts:
EVC Group, Inc.
Michael Polyviou/Todd Kehrli
(732) 232-6914
mpolyviou@evcgroup.com; tkehrli@evcgroup.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-inc-to-report-second-quarter-2022-results-on-august-11-2022-301594613.html
SOURCE BIOLASE, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.